Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sironax
Private Company Edition: Sironax completed a $200m series B round while IDRx launched with $122m and OriCell raised $120m in series C funds, joining end-of-July $100m-plus fundraiser Carmot Therapeutics, which closed a $160m series D financing.
- Other Names / Subsidiaries
- Viteruilong (Beijing) Biotechnology Co., Ltd.